| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/22/2004 | US20040014162 Regulating levels of tyrosine phosphatase activity of protein tyrosine phosphatase zeta/receptor-like protein (RPTP beta/zeta) in cells and/or tissues; antitumor agents; angiogensis inhibitors |
| 01/22/2004 | US20040014158 Protein conjugates, methods, vectors, proteins and DNA for producing them, their use, and medicaments and vaccines containing a certain quantity of said protein conjugates |
| 01/22/2004 | US20040014148 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein |
| 01/22/2004 | US20040014145 Monoclonal antibody with affinity to defective transferrin for diagnosing alcoholism; immunoassay |
| 01/22/2004 | US20040014144 Method of screening for substances acting on MSK1 |
| 01/22/2004 | US20040014135 Molecules that modulate Galphaq avtivity and methods of treating urinary incontinence |
| 01/22/2004 | US20040014134 Two coloured fluorimetric protease assay |
| 01/22/2004 | US20040014132 Comprises immunoglobulins which binds and neutralizes chemoattractants (eotaxin) for modulating inflammatory response; antiinflammtory agents; antiallergens |
| 01/22/2004 | US20040014129 Amplification primer pairs and use thereof |
| 01/22/2004 | US20040014128 Comprises nucleotide sequences coding green fluorescent proteins derivative for use as diagnostic tools genetic engineering |
| 01/22/2004 | US20040014123 Nucleotide sequences coding for the export of branched-chain amino acids, process for the isolation thereof and use thereof |
| 01/22/2004 | US20040014119 Method of detecting nucleic acids |
| 01/22/2004 | US20040014117 Includes an amplification device which permits the amplification of polynucleotides and an analysis device which quantifies the amount of the amplified polynucleotide products; automated apparatus |
| 01/22/2004 | US20040014116 Plant caffeic acid 3-0-methyltransferase homologs |
| 01/22/2004 | US20040014113 Method for efficient RNA interference in mammalian cells |
| 01/22/2004 | US20040014112 Novel human kinase proteins and polynucleotides encoding the same |
| 01/22/2004 | US20040014111 Methods for the identification of IKKalpha function and other genes useful for treatment of imflammatory diseases |
| 01/22/2004 | US20040014110 Dendritic enriched secreted lymphocyte activation molecule |
| 01/22/2004 | US20040014108 Oligonucleotides having modified nucleoside units |
| 01/22/2004 | US20040014105 Methods for the enrichment of low-abundance polynucleotides |
| 01/22/2004 | US20040014104 Methods for disease detection |
| 01/22/2004 | US20040014100 Methods and compositions utilizing inteins to generate libraries of cyclic peptides in vivo |
| 01/22/2004 | US20040014098 Integrated treatment of biomass from a cell culture process for producing clear cell lysate containing plasmid DNA, and a plasmid DNA cell lysate produced by the method |
| 01/22/2004 | US20040014092 Production of transgenic plants which synthesize long-chain inulin due to the introduction of nucleic acid molecules encoding a fructosyl transferase |
| 01/22/2004 | US20040014089 Culturing a transformant in a medium, allowing the polypeptide having phospholipase a2 activity fo form and accumulating in the culture, recovering the polypeptide thus formed |
| 01/22/2004 | US20040014088 Oligonucleotide sequence formula for labeling oligonucleotide probes and proteins for in-situ analysis |
| 01/22/2004 | US20040014085 Design of unpaired forward and reverse primers having homology to 5' end of one template and to the 3' end of another template; genetic engineering |
| 01/22/2004 | US20040014084 Method for drying water-borne materials |
| 01/22/2004 | US20040014074 Nucleic acid and proteins showing increasing expression dose under salt stress |
| 01/22/2004 | US20040014072 Novel dna synthase |
| 01/22/2004 | US20040014070 Use of silica material in an amplification reaction |
| 01/22/2004 | US20040014064 Therapeutics and diagnostics for disorders of erythropoiesis |
| 01/22/2004 | US20040014057 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 01/22/2004 | US20040014055 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
| 01/22/2004 | US20040014054 Biosensor chip |
| 01/22/2004 | US20040014052 Process for regulating gene expression |
| 01/22/2004 | US20040014051 Antisense modulation of breast cancer-1 expression |
| 01/22/2004 | US20040014050 Antisense modulation of EDG8 expression |
| 01/22/2004 | US20040014049 Used for treatment of diseases associated with expression of protein kinase C-iota ; cancer |
| 01/22/2004 | US20040014048 Antisense modulation of dual specific phosphatase 6 expression |
| 01/22/2004 | US20040014047 LIM is an acronym for 3 gene products Lin-11, Isl-1 and Mec-3 (it is a serine/threonine kinase); oligonucleotides that specifically hybridizable with nucleic acids encoding LIM domain kinase 1 |
| 01/22/2004 | US20040014046 Preparing candidate vaccine agents based on a polypeptide comprising an envelope protein of a pathogenic strain of the retrovirus and selecting as the vaccine a modified polypeptide that induces an immune response |
| 01/22/2004 | US20040014041 Facilitates the design of artifacts by a process of participative refinement; this process being analogous to natural selection as it operates in biological populations |
| 01/22/2004 | US20040014040 Identification of toxicity markers in tissues or cells exposed to a known cardiotoxin; the genes may be used as toxicity markers in drug screening and toxicity assays |
| 01/22/2004 | US20040014038 G-protein coupled receptor (GPCR) polypeptides, vectors, host cells, antibodies, and recombinant methods for producing nucleic acids/polypeptides; methods for diagnosis, treatment, and prevention of disorders involving these human proteins |
| 01/22/2004 | US20040014037 Release factors (RF-1) polypeptides and DNA (RNA) encoding RF-1 polypetides and methods for producing such polypeptides by recombinant techniques; utilizing RF-1 polypeptides to screen for antibiotics |
| 01/22/2004 | US20040014036 Transcriptional activation system, activators, and uses therefor |
| 01/22/2004 | US20040014034 Method of producing a recombinant virus |
| 01/22/2004 | US20040014033 Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
| 01/22/2004 | US20040014032 Nucleic acids encoding lettuce big-vein virus proteins and utilization thereof |
| 01/22/2004 | US20040014031 Improved packaging cell-lines and methods for the production of recombinant Adeno-Associated Viruses (rAAV); can be used in a number of applications necessitating the over-expression of a gene in a cell |
| 01/22/2004 | US20040014030 Enzymatic assay of HIV protease inhibitors |
| 01/22/2004 | US20040014025 Using a transfer system which is contacted with the cell to be changed, the transfer system comprises a fusion protein which is transferred into the cell using the VirB/VirD4 transfer system |
| 01/22/2004 | US20040013739 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 01/22/2004 | US20040013719 Regulation of cell proliferation and differentiation using topically applied nucleric acid molecules |
| 01/22/2004 | US20040013690 Attenuated Listeria spp. and methods for using the same |
| 01/22/2004 | US20040013687 Complexing Clostridium botulinum; translocation; induction immunology response |
| 01/22/2004 | US20040013686 Surface exposure epitope of loops of Neisseria; induction antibodies; competitive binding |
| 01/22/2004 | US20040013677 Mixtures; for therapy, prevention; purity polypeptide |
| 01/22/2004 | US20040013673 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria |
| 01/22/2004 | US20040013672 Recombinant antibodies, and compositions and methods for making and using the same |
| 01/22/2004 | US20040013670 Humanena/VASP-like protein splice variant |
| 01/22/2004 | US20040013668 Polypeptide antibody which binds to low density lipoprotein; quantitative analysis |
| 01/22/2004 | US20040013655 Mutant Dna; transcription of genomes |
| 01/22/2004 | US20040013654 Oligonucleotide-facilitated coalescence |
| 01/22/2004 | US20040013653 Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins |
| 01/22/2004 | US20040013650 Adjust concentration of circulating genes; in situ transformation of muscle by injecting virus vector |
| 01/22/2004 | US20040013649 Antitumor agents; nucleic acid, lipid complex |
| 01/22/2004 | US20040013648 Vector system |
| 01/22/2004 | US20040013645 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/22/2004 | US20040013607 Conjugated to Y-90 through aminohexyl diethylenetriaminepentaacetic acid chelating agent |
| 01/22/2004 | US20040012105 For use as support materials for ion exchangers, for polymer-supported liquid-phase syntheses, for oligonucleotide synthesis, for combinatorial synthesis and solid-phase synthesis; narrow distribution of particle size, uniform shape |
| 01/22/2004 | DE10248361A1 Unterdrückung eines Geschlechtes durch die Veränderung von Geschlechtschromosomen Suppression of sex by the change of sex chromosomes |
| 01/22/2004 | DE10228260A1 Methode und Vorrichtung zum impedimetrischen Nachweis eines oder mehrerer Analyten in einer Probe Method and apparatus for impedimetric detection of one or more analytes in a sample |
| 01/22/2004 | CA2621517A1 Production of polyketides fkbp-ligand analogues |
| 01/22/2004 | CA2494245A1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 01/22/2004 | CA2493871A1 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 01/22/2004 | CA2493675A1 Genes |
| 01/22/2004 | CA2493111A1 Diagnosis and prevention of cancer cell invasion |
| 01/22/2004 | CA2492859A1 Modulating developmental pathways in plants |
| 01/22/2004 | CA2492856A1 Rhodococcus equi mutants and vaccines comprising same |
| 01/22/2004 | CA2492783A1 Method of transferring mutation into target nucleic acid |
| 01/22/2004 | CA2492772A1 Activated checkpoint therapy and methods of use thereof |
| 01/22/2004 | CA2492716A1 Brachyspira hyodysenteriae vaccine |
| 01/22/2004 | CA2492711A1 Herbicide-resistant plants, and polynucleotides and methods for providing same |
| 01/22/2004 | CA2492691A1 Streptococcus pneumoniae pbp2x mini-protein and uses thereof |
| 01/22/2004 | CA2492658A1 Information processing system using base sequence relevant information |
| 01/22/2004 | CA2492642A1 Process for producing a decaffeinated coffee plant by genetic recombination |
| 01/22/2004 | CA2492559A1 Mcam inhibitors |
| 01/22/2004 | CA2492556A1 Hsp70 from arthrobacter |
| 01/22/2004 | CA2492469A1 Spliceosome mediated rna trans-splicing for correction of skin disorders |
| 01/22/2004 | CA2492364A1 High yielding soybean plants with increased seed protein plus oil |
| 01/22/2004 | CA2492355A1 Method for diagnosis of intestinal-type gastric tumors |
| 01/22/2004 | CA2492313A1 Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases |
| 01/22/2004 | CA2492213A1 Detection of target molecules using serrs reactive particles |
| 01/22/2004 | CA2492208A1 Deprotection and purification of oligonucleotides and their derivatives |
| 01/22/2004 | CA2492203A1 Synthetic tag genes |
| 01/22/2004 | CA2492136A1 Nuclear fertility restorer genes and methods of use in plants |
| 01/22/2004 | CA2492099A1 Improved transporters and their uses |
| 01/22/2004 | CA2492089A1 Delivery system for pharmaceutical agents |